A young woman has become became the first person in Britain to receive the Moderna vaccine.
Unpaid carer Elle Taylor received the Moderna jab from staff nurse Laura French at West Wales General Hospital’s outpatients department.
Speaking after receiving the vaccine, the 24-year-old said: “I’m very excited and very happy.
“I’m an unpaid carer for my grandmother so it is very important to me that I get it, so I can care for her properly and safely.
“My grandmother has had her first dose and she is going for her second dose on Saturday.”
Miss Taylor said she only found out on Tuesday evening that she was to be the first Briton to receive the Moderna jab in the UK.
She said she had not heard of the Moderna vaccine until she was told she was receiving it.
“It was great – the nurses were lovely and it didn’t hurt,” she said.
Miss Taylor said she was aware of concerns about patients receiving the Oxford/AstraZeneca vaccine developing blood clots.
“I had heard but it doesn’t concern me too much, and I guess if it happens, it happens and I am in the right care if I need it, and I feel happy that I’ve tried the new one.”
Asked how she felt to be a trailblazer for millions of other people, the 24-year-old unpaid carer said: “I feel thrilled and really happy and honoured, and I just hope it goes well for everybody.”
How effective is Moderna vaccine against coronavirus?
The phase three results suggested vaccine efficacy against the disease was 94.1%, and vaccine efficacy against severe Covid-19 was 100%.
More than 30,000 people in the US took part in the trial, from a wide range of age groups and ethnic backgrounds.
Two doses were given 28 days apart so researchers could evaluate safety and any reaction to the vaccine.
The analysis was based on 196 cases, of which 185 cases of Covid-19 were observed in the placebo group versus 11 cases observed in the active vaccine group.
Moderna also released data relating to severe cases.
All 30 severe cases occurred in the placebo group and none in the group which had received the vaccine, known as mRNA-1273.
Who developed the vaccine?
Moderna is a US pharmaceutical and biotechnology company with its headquarters in Cambridge, Massachusetts.
The vaccine received funding from two US federal agencies – the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).
Dolly Parton is credited with helping fund the jab after donating one million dollars (about £716,000) to Vanderbilt University Medical Centre in Nashville, Tennessee, which participated in the research.
The singer broadcast herself receiving the jab on social media, adapting one of her most famous hits for the occasion.
To the tune of Jolene, Parton sang: “Vaccine, vaccine, vaccine, vaccine, I’m begging of you, please don’t hesitate. Vaccine, vaccine, vaccine, vaccine, because once you’re dead, then that’s a bit too late.”
How many doses of Moderna does the UK have?
The Government has bought 17 million doses – enough to vaccinate about 8.5 million people.
A benefit of the Moderna vaccine is that it can be safely stored at temperatures of around minus 20C (minus 4F) – achievable in a standard pharmaceutical fridge – making distribution much easier.
The Pfizer vaccine on the other hand has to be stored at minus 70C (minus 94F) and is only stable for a short period at higher temperatures, making it difficult to administer away from hospital hubs.
The Moderna jab can be stored for about 30 days before use.